[
  {
    "trial_id": "NCT04567890",
    "molecule_name": "Metformin",
    "disease": "NASH",
    "phase": "2",
    "sponsor": "Mayo Clinic",
    "status": "Active",
    "start_date": "2023-06-15",
    "estimated_completion": "2025-12-30",
    "enrollment": 200,
    "primary_endpoint": "Reduction in liver fat content"
  },
  {
    "trial_id": "NCT04567903",
    "molecule_name": "Metformin",
    "disease": "NASH",
    "phase": "2b",
    "sponsor": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
    "status": "Recruiting",
    "start_date": "2023-01-10",
    "estimated_completion": "2026-06-15",
    "enrollment": 350,
    "primary_endpoint": "Resolution of NASH without worsening of fibrosis"
  },
  {
    "trial_id": "NCT04567916",
    "molecule_name": "Metformin",
    "disease": "NASH",
    "phase": "3",
    "sponsor": "European NASH Registry",
    "status": "Not yet recruiting",
    "start_date": "2024-02-01",
    "estimated_completion": "2027-12-31",
    "enrollment": 1200,
    "primary_endpoint": "Improvement in liver fibrosis by at least one stage without worsening of NASH"
  },
  {
    "trial_id": "CT-001",
    "molecule_name": "Metformin",
    "disease": "Alzheimer's Disease",
    "phase": 2,
    "sponsor": "NeuroPharm Inc.",
    "status": "Active"
  },
  {
    "trial_id": "CT-002",
    "molecule_name": "Aspirin",
    "disease": "Colorectal Cancer Prevention",
    "phase": 3,
    "sponsor": "OncoLife Research",
    "status": "Completed"
  },
  {
    "trial_id": "CT-003",
    "molecule_name": "Semaglutide",
    "disease": "Nonalcoholic Fatty Liver Disease",
    "phase": 2,
    "sponsor": "LiverTech Bio",
    "status": "Active"
  },
  {
    "trial_id": "CT-004",
    "molecule_name": "Atorvastatin",
    "disease": "Multiple Sclerosis",
    "phase": 2,
    "sponsor": "NeuroStat Therapeutics",
    "status": "Completed"
  },
  {
    "trial_id": "CT-005",
    "molecule_name": "Losartan",
    "disease": "Diabetic Nephropathy",
    "phase": 3,
    "sponsor": "Renal Health Corp.",
    "status": "Active"
  },
  {
    "trial_id": "CT-006",
    "molecule_name": "Dapagliflozin",
    "disease": "Heart Failure with Preserved Ejection Fraction",
    "phase": 3,
    "sponsor": "CardioLife Labs",
    "status": "Completed"
  },
  {
    "trial_id": "CT-007",
    "molecule_name": "Paracetamol",
    "disease": "Migraine Prophylaxis",
    "phase": 1,
    "sponsor": "PainRelief Biotech",
    "status": "Active"
  },
  {
    "trial_id": "CT-008",
    "molecule_name": "Hydroxychloroquine",
    "disease": "Type 1 Diabetes",
    "phase": 2,
    "sponsor": "Autoimmune Solutions",
    "status": "Completed"
  },
  {
    "trial_id": "CT-009",
    "molecule_name": "Rivaroxaban",
    "disease": "Cancer-Associated Thrombosis",
    "phase": 3,
    "sponsor": "OncoCardia Ltd.",
    "status": "Active"
  },
  {
    "trial_id": "CT-010",
    "molecule_name": "Naproxen",
    "disease": "Osteoarthritis",
    "phase": 3,
    "sponsor": "OrthoThera Inc.",
    "status": "Completed"
  }
]
